Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2004
08/04/2004EP1441656A1 Method and apparatus for production of a skin graft and the graft produced thereby
08/04/2004EP1361850A4 Use of (gamma-hydroxy-n-methyl-l-leucine9) cyclosporin a for hair growth
08/04/2004EP1337236B1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
08/04/2004EP1313772B1 New cross-linked derivatives of hyaluronic acid
08/04/2004EP1261628A4 Novel molecules of the card-related protein family and uses thereof
08/04/2004EP1202730B1 Use of ep4 receptor ligands in the treatment of neuropathic pain
08/04/2004EP1171465B1 Analogs of gastric inhibitory peptide and their use for treatment of diabetes
08/04/2004EP1171151A4 Thrombospondin-2 and uses thereof
08/04/2004EP1169054B1 Prognosis of ptp lar related diseases
08/04/2004EP1127071B1 Compounds with growth hormone releasing properties
08/04/2004EP1126879A4 Gene therapy for regulating smooth muscle cell tone
08/04/2004EP1096947B1 Topical drug for the treatment of viral infections
08/04/2004EP1034001B1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome
08/04/2004EP0996462B1 Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
08/04/2004EP0981542B1 20(s) camptothecin glycoconjugates
08/04/2004EP0975665B1 Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues
08/04/2004EP0764171B1 Ligands for induction of antigen specific apoptosis in t cells
08/04/2004EP0761229B1 Corneal vascularization inhibitor
08/04/2004EP0637963B1 Cd28 pathway immunoregulation
08/04/2004CN1518598A Serpin in Bifidobacteria
08/04/2004CN1518597A Novel fibroblast growth factors
08/04/2004CN1518595A 修饰的精氨酸脱亚胺酶 Modified arginine deiminase
08/04/2004CN1518592A Male contraceptives
08/04/2004CN1518567A Linear block polymer
08/04/2004CN1518558A Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament
08/04/2004CN1518462A Pharmaceutical formulation
08/04/2004CN1518461A Medicinal compositions
08/04/2004CN1518458A Graft rejection inhibitors
08/04/2004CN1518455A Anti-bacterial agent
08/04/2004CN1518452A Oral delivery of macromolecules
08/04/2004CN1518442A Pharmaceutical compositions comprising cyclosporin
08/04/2004CN1518441A Particles for inhalation having rapid release properties
08/04/2004CN1517365A Bifunctional chimeric profein possessing inhibiting leucocyte function and thrombin activity
08/04/2004CN1517364A Deletion type human interleukin 11 microvariant
08/04/2004CN1517363A Novel human keratinocyte growth factor mutant
08/04/2004CN1517126A Drug compastion with thrombolysis, anti-inflammatory and cell protective function
08/04/2004CN1517125A Recombination human granul ocyte-macrophage colong stimulating factor ges and its preparation method
08/04/2004CN1160469C Identification of genes
08/04/2004CN1160462C Use of gram-positive bacteria to express recombinant proteins
08/04/2004CN1160457C Recombinant mistletoe lectin (rML)
08/04/2004CN1160371C NOTCH protein and their ligands
08/04/2004CN1160370C Novel human cell cysle control related protein and sequence encoding the same
08/04/2004CN1160368C Endothelin antegon
08/04/2004CN1160123C Use of ulinastatin in treating SARS and medicinal composition thereof
08/04/2004CN1160122C Method of preparing oil-phase oral insulin preparation
08/04/2004CN1160121C Growth hormone liposome for pig and its preparation method
08/04/2004CN1160120C Method for producing anti-cancer medicine from silkworm
08/04/2004CN1160119C Functions for Tob gene in central nervous system of mammol and its application
08/04/2004CN1160118C Histone containing compsn. to treat rheumatoid arthritis
08/04/2004CN1160117C Bone-repairing material preparing method
08/04/2004CN1160116C Specific immunological inhibitor
08/04/2004CN1160115C Irrigation solution and method for inhibition of pain, inflammation and spasm
08/04/2004CN1160075C Use of heterocyclic amide compound for preparing IgE antibody production inhibitors
08/04/2004CN1160059C Process of generating submicron particles of water-insuluble compounds
08/03/2004US6770797 Inducing prolonged in vivo gene expression in a mammal for inhibiting alzheimer's disease associated neuronal cell death
08/03/2004US6770746 Chemical modification of proteins to improve biocompatibility and bioactivity
08/03/2004US6770745 Common gamma chain blocking agents
08/03/2004US6770744 Genetically engineered antihemophilic factor for use in the treatment of blood disorders
08/03/2004US6770743 Genetic engineered drug
08/03/2004US6770742 Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer
08/03/2004US6770741 Useful in treating conditions and diseases of a mammal and human in which an excess of bradykinin or related kinins are produced or injected such as by insect bites
08/03/2004US6770738 Used to modulate protein activity through, for example, transcription arrest, transcription initiation, and site specific cleavage of nucleic acids
08/03/2004US6770666 Fused-ring compounds and use thereof as drugs
08/03/2004US6770633 Ribozyme therapy for the treatment of proliferative skin and eye diseases
08/03/2004US6770632 Folypolyglutamyl synthetase gene transfer to enhance antifolate
08/03/2004US6770631 Non-identical genes and their application in improved molecular adjuvants
08/03/2004US6770628 Hematopoietic stimulation
08/03/2004US6770627 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p 53
08/03/2004US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors
08/03/2004US6770624 Heart failure following myocardial infarction is treated by administration of an angiotensin ii inhibitor for 10 weeks, followed by administration of a growth hormone
08/03/2004US6770623 Stabilized teriparatide solutions
08/03/2004US6770622 Tumors, and metastasis
08/03/2004US6770621 Polyacid glycopeptide derivatives
08/03/2004US6770620 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
08/03/2004US6770619 Lung surfactant compositions with dynamic swelling behavior
08/03/2004US6770595 Cyclic imines as pesticides
08/03/2004US6770474 Nucleotide sequences for use in diagnosis and treatment of viral, liver, nervous system, autoimmune and tumoral diseases
08/03/2004US6770473 Wild-type and mutant human kinase interacting strathmin (hkis) polypeptides along with cyclin kinase inhibitors containing mutations that prevent their inhibition with serine/ threonine kinases
08/03/2004US6770468 Nucleotide and amino sequences of the lysosomal targeting pathway enzyme phosphodiester alpha - glcnacase, methods of producing and methods of purifying this enzyme
08/03/2004US6770466 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders
08/03/2004US6770461 High bone mass gene of 11q13.3
08/03/2004US6770458 Tgf- transforming growth factor
08/03/2004US6770457 Process of purifying angiogenesis inhibitors
08/03/2004US6770455 Preparation, use and medicaments containing ribonucleotide polypeptides or their molecular-biological equivalent structures and/or parts and/or derivatives
08/03/2004US6770448 Fluorescent amyloid Aβ peptides and uses thereof
08/03/2004US6770444 Methods of identifying or screening for agents that binds the Ob-Re
08/03/2004US6770438 Oncogene, oncoprotein; associated with tumorigenicity; mn genes from cellular component of matu, a quasi viral agent derived from a human mammary tumor
08/03/2004US6770306 Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof
08/03/2004US6770292 Pharmaceutical compositions for oral administration
08/03/2004US6770276 Insulin-containing medicament for peroral application and method for the production thereof
08/03/2004US6770272 Treatment of diabetes
08/03/2004CA2271095C Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation
08/03/2004CA2233457C Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
08/03/2004CA2142599C Method for diagnosing and monitoring sepsis
08/03/2004CA2089111C Smooth muscle mitogen and isolated dna coding therefor
08/03/2004CA2070230C Crystalline oxathiolane derivatives
08/03/2004CA2041093C A pharmacological composition containing polyelectrolyte complexes in microparticulate form and at least one active substance
07/2004
07/29/2004WO2004063963A2 Novel proteins with altered immunogenicity
07/29/2004WO2004063376A1 Method for preparing recombinant heterocarpine
07/29/2004WO2004063365A1 NOVEL USE OF COMPOUND HAVING TGFβ-INHIBITORY ACTIVITY